WELLS FARGO & COMPANY/MN - TITAN PHARMACEUTICALS INC DE ownership

TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314606. A total of 26 filers reported holding TITAN PHARMACEUTICALS INC DE in Q1 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of TITAN PHARMACEUTICALS INC DE
ValueSharesWeighting
Q3 2023$40
-25.9%
84
+1.2%
0.00%
Q2 2023$54
-16.9%
83
+6.4%
0.00%
Q1 2023$65
+8.3%
78
+1.3%
0.00%
Q4 2022$6077
+2.7%
0.00%
Q3 2022$075
-7.4%
0.00%
Q2 2022$081
+19.1%
0.00%
Q1 2022$068
+13.3%
0.00%
Q4 2021$0600.0%0.00%
Q3 2021$060
+30.4%
0.00%
Q2 2021$0460.0%0.00%
Q1 2021$046
+2.2%
0.00%
Q4 2020$0450.00%
Other shareholders
TITAN PHARMACEUTICALS INC DE shareholders Q1 2021
NameSharesValueWeighting ↓
tru Independence LLC 3,500$11,515,0000.02%
Tower Research Capital LLC (TRC) 7,972$26,0000.00%
Westside Investment Management, Inc. 8$00.00%
American Portfolios Advisors 23$760.00%
ROYAL BANK OF CANADA 1$00.00%
VANGUARD GROUP INC 56,691$186,0000.00%
Advisory Services Network, LLC 2,000$7,0000.00%
UBS Group AG 6,062$20,0000.00%
Sowell Financial Services LLC 19$00.00%
OSAIC HOLDINGS, INC. 15$00.00%
View complete list of TITAN PHARMACEUTICALS INC DE shareholders